SB-509

· Sangamo Therapeutics

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SB-509, covering 2012-11-01 to 2022-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy [Phase 2]